+Follow
Jillwong26
No personal profile
5
Follow
1
Followers
0
Topic
0
Badge
Posts
Hot
Jillwong26
2021-07-21
[OMG]
Johnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says study
Jillwong26
2021-07-20
[Smug]
4 Ways I'm Preparing for the Stock Market Bubble to Burst
Jillwong26
2021-07-20
Like and share
Netflix, AT&T, Snap, Chipotle, Twitter, and Other Stocks for Investors to Watch This Week
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4089540340634350","uuid":"4089540340634350","gmtCreate":1626437880060,"gmtModify":1626750424298,"name":"Jillwong26","pinyin":"jillwong26","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/361c1d2946a05e887ab9e2177a2f2486","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":5,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":176048324,"gmtCreate":1626849278368,"gmtModify":1703479244841,"author":{"id":"4089540340634350","authorId":"4089540340634350","name":"Jillwong26","avatar":"https://static.tigerbbs.com/361c1d2946a05e887ab9e2177a2f2486","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089540340634350","authorIdStr":"4089540340634350"},"themes":[],"htmlText":"[OMG] ","listText":"[OMG] ","text":"[OMG]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/176048324","repostId":"2153866611","repostType":4,"repost":{"id":"2153866611","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1626847800,"share":"https://ttm.financial/m/news/2153866611?lang=&edition=fundamental","pubTime":"2021-07-21 14:10","market":"sh","language":"en","title":"Johnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says study","url":"https://stock-news.laohu8.com/highlight/detail?id=2153866611","media":"Dow Jones","summary":"JNJ says data from study 'do not speak to the full nature of immune protection'.\n\nThe one-shot coron","content":"<blockquote>\n JNJ says data from study 'do not speak to the full nature of immune protection'.\n</blockquote>\n<p>The <a href=\"https://laohu8.com/S/AONE.U\">one</a>-shot coronavirus vaccine from Johnson & Johnson is much less effective against the Delta variant than it is against the original version of COVID-19, according to a new study posted online Tuesday.</p>\n<p>The study, which examined blood samples in a laboratory setting and has not yet been peer-reviewed, suggests that anyone who received the J&J <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> vaccine may need to receive a second shot as the variant continues to spread across the US.</p>\n<p>\"The message that we wanted to give was not that people shouldn't get the J&J vaccine, but we hope that in the future, it will be boosted with either another dose of J&J or a boost with Pfizer or Moderna,\" study leader Nathaniel Landau, a virologist at NYU's Grossman School of Medicine, told The New York Times .</p>\n<p>Earlier this month, New Jersey-based Johnson & Johnson published preliminary data indicating its vaccine was effective against the Delta variant, first located in India, at least eight months after inoculation.</p>\n<p>However, in May, the British government released a study vaccine, which is similar in structure to the Johnson & Johnson vaccine, was just 33 percent effective against \"symptomatic disease\" caused by the Delta variant, while two doses were 60 percent effective against symptomatic disease.</p>\n<p>J&J spokesperson Seema Kumar told the Times that the data from the latest study \"do not speak to the full nature of immune protection.\"</p>\n<p>Last month, Centers for Disease Control and Prevention <a href=\"https://laohu8.com/S/CDC\">$(CDC)$</a> Director Dr. Rochelle Walensky told NBC's \"Today\" show that \"we have every reason to believe ... that the J&J will perform well against the Delta variant, as it has so far against other variants circulating in the United States.\"</p>\n<p>Walensky told lawmakers earlier Tuesday that the Delta variant currently accounts for 83 percent of all COVID-19 cases in the US. During the same hearing, White House chief medical adviser Dr. Anthony Fauci said researchers were still assessing whether booster shots would be needed to provide additional protection.</p>\n<p>\"We don't want people to believe that when you're talking about boosters, that means the vaccines aren't effective,\" Fauci said. \"They are highly effective, we are talking about the durability of that.\"</p>\n<p>Initial studies indicate that mRNA vaccines manufactured by Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> and Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> are effective against the Delta variant and could provide protection for years, provided the virus doesn't mutate far beyond its initial form.</p>\n<p>The Delta variant has been blamed for an increase in cases, hospitalizations and deaths in recent weeks, though the numbers in all categories are still well below the peak of last winter's surge and the overwhelming majority of hospitalizations and deaths are occurring among unvaccinated people.</p>\n<p>Despite that, health officials in Los Angeles and Las Vegas have reimposed mask mandates in indoor spaces, regardless of individuals' vaccination status.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Johnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJohnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-07-21 14:10</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n JNJ says data from study 'do not speak to the full nature of immune protection'.\n</blockquote>\n<p>The <a href=\"https://laohu8.com/S/AONE.U\">one</a>-shot coronavirus vaccine from Johnson & Johnson is much less effective against the Delta variant than it is against the original version of COVID-19, according to a new study posted online Tuesday.</p>\n<p>The study, which examined blood samples in a laboratory setting and has not yet been peer-reviewed, suggests that anyone who received the J&J <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> vaccine may need to receive a second shot as the variant continues to spread across the US.</p>\n<p>\"The message that we wanted to give was not that people shouldn't get the J&J vaccine, but we hope that in the future, it will be boosted with either another dose of J&J or a boost with Pfizer or Moderna,\" study leader Nathaniel Landau, a virologist at NYU's Grossman School of Medicine, told The New York Times .</p>\n<p>Earlier this month, New Jersey-based Johnson & Johnson published preliminary data indicating its vaccine was effective against the Delta variant, first located in India, at least eight months after inoculation.</p>\n<p>However, in May, the British government released a study vaccine, which is similar in structure to the Johnson & Johnson vaccine, was just 33 percent effective against \"symptomatic disease\" caused by the Delta variant, while two doses were 60 percent effective against symptomatic disease.</p>\n<p>J&J spokesperson Seema Kumar told the Times that the data from the latest study \"do not speak to the full nature of immune protection.\"</p>\n<p>Last month, Centers for Disease Control and Prevention <a href=\"https://laohu8.com/S/CDC\">$(CDC)$</a> Director Dr. Rochelle Walensky told NBC's \"Today\" show that \"we have every reason to believe ... that the J&J will perform well against the Delta variant, as it has so far against other variants circulating in the United States.\"</p>\n<p>Walensky told lawmakers earlier Tuesday that the Delta variant currently accounts for 83 percent of all COVID-19 cases in the US. During the same hearing, White House chief medical adviser Dr. Anthony Fauci said researchers were still assessing whether booster shots would be needed to provide additional protection.</p>\n<p>\"We don't want people to believe that when you're talking about boosters, that means the vaccines aren't effective,\" Fauci said. \"They are highly effective, we are talking about the durability of that.\"</p>\n<p>Initial studies indicate that mRNA vaccines manufactured by Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> and Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> are effective against the Delta variant and could provide protection for years, provided the virus doesn't mutate far beyond its initial form.</p>\n<p>The Delta variant has been blamed for an increase in cases, hospitalizations and deaths in recent weeks, though the numbers in all categories are still well below the peak of last winter's surge and the overwhelming majority of hospitalizations and deaths are occurring among unvaccinated people.</p>\n<p>Despite that, health officials in Los Angeles and Las Vegas have reimposed mask mandates in indoor spaces, regardless of individuals' vaccination status.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153866611","content_text":"JNJ says data from study 'do not speak to the full nature of immune protection'.\n\nThe one-shot coronavirus vaccine from Johnson & Johnson is much less effective against the Delta variant than it is against the original version of COVID-19, according to a new study posted online Tuesday.\nThe study, which examined blood samples in a laboratory setting and has not yet been peer-reviewed, suggests that anyone who received the J&J $(JNJ)$ vaccine may need to receive a second shot as the variant continues to spread across the US.\n\"The message that we wanted to give was not that people shouldn't get the J&J vaccine, but we hope that in the future, it will be boosted with either another dose of J&J or a boost with Pfizer or Moderna,\" study leader Nathaniel Landau, a virologist at NYU's Grossman School of Medicine, told The New York Times .\nEarlier this month, New Jersey-based Johnson & Johnson published preliminary data indicating its vaccine was effective against the Delta variant, first located in India, at least eight months after inoculation.\nHowever, in May, the British government released a study vaccine, which is similar in structure to the Johnson & Johnson vaccine, was just 33 percent effective against \"symptomatic disease\" caused by the Delta variant, while two doses were 60 percent effective against symptomatic disease.\nJ&J spokesperson Seema Kumar told the Times that the data from the latest study \"do not speak to the full nature of immune protection.\"\nLast month, Centers for Disease Control and Prevention $(CDC)$ Director Dr. Rochelle Walensky told NBC's \"Today\" show that \"we have every reason to believe ... that the J&J will perform well against the Delta variant, as it has so far against other variants circulating in the United States.\"\nWalensky told lawmakers earlier Tuesday that the Delta variant currently accounts for 83 percent of all COVID-19 cases in the US. During the same hearing, White House chief medical adviser Dr. Anthony Fauci said researchers were still assessing whether booster shots would be needed to provide additional protection.\n\"We don't want people to believe that when you're talking about boosters, that means the vaccines aren't effective,\" Fauci said. \"They are highly effective, we are talking about the durability of that.\"\nInitial studies indicate that mRNA vaccines manufactured by Moderna $(MRNA)$ and Pfizer $(PFE)$ BioNTech $(BNTX)$ are effective against the Delta variant and could provide protection for years, provided the virus doesn't mutate far beyond its initial form.\nThe Delta variant has been blamed for an increase in cases, hospitalizations and deaths in recent weeks, though the numbers in all categories are still well below the peak of last winter's surge and the overwhelming majority of hospitalizations and deaths are occurring among unvaccinated people.\nDespite that, health officials in Los Angeles and Las Vegas have reimposed mask mandates in indoor spaces, regardless of individuals' vaccination status.","news_type":1},"isVote":1,"tweetType":1,"viewCount":268,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171196206,"gmtCreate":1626710622005,"gmtModify":1703763876126,"author":{"id":"4089540340634350","authorId":"4089540340634350","name":"Jillwong26","avatar":"https://static.tigerbbs.com/361c1d2946a05e887ab9e2177a2f2486","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089540340634350","authorIdStr":"4089540340634350"},"themes":[],"htmlText":"[Smug] ","listText":"[Smug] ","text":"[Smug]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/171196206","repostId":"2152827296","repostType":4,"repost":{"id":"2152827296","kind":"highlight","pubTimestamp":1626663600,"share":"https://ttm.financial/m/news/2152827296?lang=&edition=fundamental","pubTime":"2021-07-19 11:00","market":"us","language":"en","title":"4 Ways I'm Preparing for the Stock Market Bubble to Burst","url":"https://stock-news.laohu8.com/highlight/detail?id=2152827296","media":"Motley Fool","summary":"This incredible rally has to end with a spectacular crash sometime ... right? Maybe.","content":"<p>Does the <b>S&P 500</b>'s nearly 100% gain from last March's low have you a little worried about a pullback? You're not alone. Even though much of this move was a recovery from the steep sell-off sparked by the onset of the COVID-19 pandemic, much of it has also just been plain old bullishness ... perhaps a little too much. Stocks are still chugging along, but at times, it feels like the only thing keeping the rally going is its momentum. That's not good.</p>\n<p>If you're concerned the market bubble is going to pop soon, feel free to rip a few pages out of my personal playbook. Notice that none of them are particularly complicated moves.</p>\n<h3>1. I'm scaling out of frothier, more speculative names</h3>\n<p>I confess, some of the names I've picked up over the course of the past year or so aren't exactly the sorts of stocks I fully intended to hold for the long haul. They were closer to being bets than investments, which can be fun and rewarding but not exactly safe when the market starts to unravel. As the old adage goes, the higher they fly, the farther they fall. That's especially true when a company can't even come close to justifying its stock price with actual fundamentals. Yes, I'm looking at you, <b>AMC Entertainment</b>.</p>\n<p>Most investors innately know this is the smart-money move to make when the broad market is closer to a major high than a major low. Some investors, however, just need to hear someone else say it. I just did.</p>\n<h3>2. I'm prioritizing cash over equities</h3>\n<p>At first glance, this seems a lot like the aforementioned move -- backing off on my exposure to riskier equities. After all, if I'm selling anything, those proceeds are inherently turned into cash anyway.</p>\n<p>To be clear, however, I'm not merely swapping out my more speculative, vulnerable names for more reliable blue chips. I'm reducing my overall exposure to the market by converting a sizable stake of my holdings to cash.</p>\n<p>It's not always a fully understood (or even believed) facet of investing, but \"safe\" stocks like consumer goods names and utilities companies aren't actually protection from a correction. Shares of consumer packaged goods giant <b>Procter & Gamble</b> fell nearly 24% between last year's February high and March low when the coronavirus began to spread across the world, including within the U.S. Utility name <b>The Southern Company</b> fell 39% during this timeframe. Both recovered -- and then some -- but neither actually offered any true defense from sweeping weakness.</p>\n<p>The point is, during market corrections, there's really no place to hide. You'll just have to let the long-term holdings you're committed to take their lumps on faith they'll bounce back. If you don't have that faith with any particular stock, just replace it with cash until the dust settles.</p>\n<h3>3. I'm adding (a little) gold</h3>\n<p>While most stocks are going to be dragged lower by a market-wide correction, not every sort of holding is a stock. There are also bonds and commodities, which still trade independently of equities. That doesn't preclude them from pulling back if and when the stock market does. But if they do peel back, they're doing so independently of the broad market.</p>\n<p>I'm not bothering with bonds right now. Interest rates are pointlessly low, and with inflation seemingly on the verge of racing out of control, bonds are little more than a coin toss at this time anyway.</p>\n<p>Commodities, however, are a different story. If anything, they've become bigger movers against a rising inflation backdrop and a Federal Reserve that's being increasingly pressured to respond. Should stocks tank, commodities -- already pumped and primed -- may see a swell of demand that drives prices higher. The easiest way to plug into this dynamic is with a simple pick like the <b>SPDR Gold Trust</b>.</p>\n<h3>4. Mostly, I'm doing nothing</h3>\n<p>Finally, and perhaps most importantly, I'm doing nothing about a possible market correction.</p>\n<p>You read that right.</p>\n<p>There are two schools of thought behind the decision to do nothing rather than trying to evade the impact of a correction. The first of these is the simple fact that most of my holdings really are long-haul positions I had (and have) every intention of hanging onto through bear markets. One of the greatest upsides of a legitimate buy-and-hold approach is that you don't even have to worry about temporary headwinds.</p>\n<p>The other idea at work here is the fact that guessing the market's next near-term reversal is just darn difficult to do ... so much so that most people don't do it very well. Indeed, the effort to time the stock market's peaks and valleys often does more harm than good, by virtue of getting you out too soon or too late, or getting you back in too soon or too late. The market's going to do what the market's going to do in its own time, and it's<i> not</i> going to telegraph what's around the corner to anyone. The best way to win that game is by not playing it at all.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Ways I'm Preparing for the Stock Market Bubble to Burst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Ways I'm Preparing for the Stock Market Bubble to Burst\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-19 11:00 GMT+8 <a href=https://www.fool.com/investing/2021/07/18/4-ways-im-preparing-for-stock-market-bubble-burst/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Does the S&P 500's nearly 100% gain from last March's low have you a little worried about a pullback? You're not alone. Even though much of this move was a recovery from the steep sell-off sparked by ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/18/4-ways-im-preparing-for-stock-market-bubble-burst/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2021/07/18/4-ways-im-preparing-for-stock-market-bubble-burst/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152827296","content_text":"Does the S&P 500's nearly 100% gain from last March's low have you a little worried about a pullback? You're not alone. Even though much of this move was a recovery from the steep sell-off sparked by the onset of the COVID-19 pandemic, much of it has also just been plain old bullishness ... perhaps a little too much. Stocks are still chugging along, but at times, it feels like the only thing keeping the rally going is its momentum. That's not good.\nIf you're concerned the market bubble is going to pop soon, feel free to rip a few pages out of my personal playbook. Notice that none of them are particularly complicated moves.\n1. I'm scaling out of frothier, more speculative names\nI confess, some of the names I've picked up over the course of the past year or so aren't exactly the sorts of stocks I fully intended to hold for the long haul. They were closer to being bets than investments, which can be fun and rewarding but not exactly safe when the market starts to unravel. As the old adage goes, the higher they fly, the farther they fall. That's especially true when a company can't even come close to justifying its stock price with actual fundamentals. Yes, I'm looking at you, AMC Entertainment.\nMost investors innately know this is the smart-money move to make when the broad market is closer to a major high than a major low. Some investors, however, just need to hear someone else say it. I just did.\n2. I'm prioritizing cash over equities\nAt first glance, this seems a lot like the aforementioned move -- backing off on my exposure to riskier equities. After all, if I'm selling anything, those proceeds are inherently turned into cash anyway.\nTo be clear, however, I'm not merely swapping out my more speculative, vulnerable names for more reliable blue chips. I'm reducing my overall exposure to the market by converting a sizable stake of my holdings to cash.\nIt's not always a fully understood (or even believed) facet of investing, but \"safe\" stocks like consumer goods names and utilities companies aren't actually protection from a correction. Shares of consumer packaged goods giant Procter & Gamble fell nearly 24% between last year's February high and March low when the coronavirus began to spread across the world, including within the U.S. Utility name The Southern Company fell 39% during this timeframe. Both recovered -- and then some -- but neither actually offered any true defense from sweeping weakness.\nThe point is, during market corrections, there's really no place to hide. You'll just have to let the long-term holdings you're committed to take their lumps on faith they'll bounce back. If you don't have that faith with any particular stock, just replace it with cash until the dust settles.\n3. I'm adding (a little) gold\nWhile most stocks are going to be dragged lower by a market-wide correction, not every sort of holding is a stock. There are also bonds and commodities, which still trade independently of equities. That doesn't preclude them from pulling back if and when the stock market does. But if they do peel back, they're doing so independently of the broad market.\nI'm not bothering with bonds right now. Interest rates are pointlessly low, and with inflation seemingly on the verge of racing out of control, bonds are little more than a coin toss at this time anyway.\nCommodities, however, are a different story. If anything, they've become bigger movers against a rising inflation backdrop and a Federal Reserve that's being increasingly pressured to respond. Should stocks tank, commodities -- already pumped and primed -- may see a swell of demand that drives prices higher. The easiest way to plug into this dynamic is with a simple pick like the SPDR Gold Trust.\n4. Mostly, I'm doing nothing\nFinally, and perhaps most importantly, I'm doing nothing about a possible market correction.\nYou read that right.\nThere are two schools of thought behind the decision to do nothing rather than trying to evade the impact of a correction. The first of these is the simple fact that most of my holdings really are long-haul positions I had (and have) every intention of hanging onto through bear markets. One of the greatest upsides of a legitimate buy-and-hold approach is that you don't even have to worry about temporary headwinds.\nThe other idea at work here is the fact that guessing the market's next near-term reversal is just darn difficult to do ... so much so that most people don't do it very well. Indeed, the effort to time the stock market's peaks and valleys often does more harm than good, by virtue of getting you out too soon or too late, or getting you back in too soon or too late. The market's going to do what the market's going to do in its own time, and it's not going to telegraph what's around the corner to anyone. The best way to win that game is by not playing it at all.","news_type":1},"isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171198788,"gmtCreate":1626710528344,"gmtModify":1703763874294,"author":{"id":"4089540340634350","authorId":"4089540340634350","name":"Jillwong26","avatar":"https://static.tigerbbs.com/361c1d2946a05e887ab9e2177a2f2486","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089540340634350","authorIdStr":"4089540340634350"},"themes":[],"htmlText":"Like and share ","listText":"Like and share ","text":"Like and share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/171198788","repostId":"1111084715","repostType":4,"repost":{"id":"1111084715","kind":"news","pubTimestamp":1626649255,"share":"https://ttm.financial/m/news/1111084715?lang=&edition=fundamental","pubTime":"2021-07-19 07:00","market":"us","language":"en","title":"Netflix, AT&T, Snap, Chipotle, Twitter, and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1111084715","media":"Barrons","summary":"Second-quarter earnings season picks up this week, as 76 S&P 500 companies are scheduled to report. ","content":"<p>Second-quarter earnings season picks up this week, as 76 S&P 500 companies are scheduled to report. <a href=\"https://laohu8.com/S/IBM\">IBM</a> and J.B. Hunt Transport Services will be Monday’s highlights, followed by Netflix, Chipotle Mexican Grill, Halliburton, Intuitive Surgical, and United Airlines Holdings on Tuesday.</p>\n<p>Wednesday will be busy, with SAP, Coca-Cola, Johnson & Johnson, Texas Instruments, and Verizon Communications all releasing results. AT&T, <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>, Biogen, Snap, American Airlines Group, Intel, and Southwest Airlines go next on Thursday, before American <a href=\"https://laohu8.com/S/EXPR\">Express</a>, Honeywell International, and Schlumberger close the week on Friday.</p>\n<p>The economic calendar this week will bring plenty of data on the state of the U.S. housing market. On Monday, the National Association of Home Builders releases its NAHB/ Wells Fargo Housing Market Index for July, followed by the Census Bureau’s new residential construction data for June on Tuesday. Then, on Thursday, the National Association of Realtors reports existing-home sales for June. Economists on average expect a still robust housing market, but one that’s less explosively growing than earlier this year.</p>\n<p><img src=\"https://static.tigerbbs.com/7e83f1e4a91566400a5dd6174a1f8ecc\" tg-width=\"1564\" tg-height=\"662\" referrerpolicy=\"no-referrer\"></p>\n<p>Monday 7/19</p>\n<p>IBM, J.B. Hunt Transport Services, PPG Industries, Prologis, Tractor Supply, and Zions Bancorp report quarterly results.</p>\n<p>L Brands holds a conference call to discuss the spinoff of its Victoria’s Secret brand. The new company, to be called Victoria’s Secret, is expected to trade under the ticker VSCO on the New York Stock Exchange in early August. The remaining company will be renamed Bath & Body Works, and also have a new stock symbol, BBWI.</p>\n<p>The National Association of Home Builders releases its NAHB/Wells Fargo Housing Market Index for July. Consensus estimate is for an 82 reading, slightly higher than the June data. Home builders remain quite bullish on the housing market, but the June figure was the lowest since August 2020, amid rising materials prices and supply-chain shortages.</p>\n<p>Tuesday 7/20</p>\n<p>Chipotle Mexican Grill, <a href=\"https://laohu8.com/S/CFG\">Citizens Financial Group</a>, Halliburton, HCA Healthcare, Intuitive Surgical, <a href=\"https://laohu8.com/S/KEY\">KeyCorp</a>, Netflix, Philip Morris International, <a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a>, Travelers, and United Airlines Holdings announce earnings.</p>\n<p>The Census Bureau reports new residential construction data for June. Economists forecast a seasonally adjusted annual rate of 1.6 million housing starts, slightly more than the June figure.</p>\n<p>Wednesday 7/21</p>\n<p>Anthem, ASML Holding, Baker Hughes, Coca-Cola, Crown Castle International, CSX, Johnson & Johnson, Nasdaq, Northern Trust, Novartis, SAP, Seagate Technology Holdings, Texas Instruments, and Verizon Communications release quarterly results.</p>\n<p>Thursday 7/22</p>\n<p>The NAR reports existing-home sales for June. Economists forecast a seasonally adjusted annual rate of 5.8 million, matching the May figure. Existing-home sales have declined for four consecutive months.</p>\n<p>Abbott Laboratories, American Airlines Group, AT&T, Biogen, Capital One Financial, D.R. Horton, Danaher, Intel, Marsh & McLennan, Newmont, Nucor, Snap, Southwest Airlines, Twitter, and Union Pacific hold conference calls to discuss earnings.</p>\n<p>The Conference Board releases its Leading Economic Index for June. Consensus estimate is for a 1.1% month-over-month increase, after a 1.3% rise in May. The LEI has now surpassed its previous peak from January 2020.</p>\n<p>The European Central Bank announces its monetary-policy decision. The central bank is widely expected to keep its key short-term interest rate unchanged at negative 0.5%. The ECB recently changed its inflation goal to 2% over the medium term instead of targeting inflation of close to, but below, 2%.</p>\n<p>Friday 7/23</p>\n<p>American Express, Honeywell International, Kimberly-Clark, NextEra Energy, and Schlumberger report quarterly results.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Netflix, AT&T, Snap, Chipotle, Twitter, and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNetflix, AT&T, Snap, Chipotle, Twitter, and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-19 07:00 GMT+8 <a href=https://www.barrons.com/articles/netflix-at-t-snap-chipotle-twitter-and-other-stocks-for-investors-to-watch-this-week-51626634814?mod=hp_LEAD_3><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Second-quarter earnings season picks up this week, as 76 S&P 500 companies are scheduled to report. IBM and J.B. Hunt Transport Services will be Monday’s highlights, followed by Netflix, Chipotle ...</p>\n\n<a href=\"https://www.barrons.com/articles/netflix-at-t-snap-chipotle-twitter-and-other-stocks-for-investors-to-watch-this-week-51626634814?mod=hp_LEAD_3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","ISBC":"投资者银行",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.barrons.com/articles/netflix-at-t-snap-chipotle-twitter-and-other-stocks-for-investors-to-watch-this-week-51626634814?mod=hp_LEAD_3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111084715","content_text":"Second-quarter earnings season picks up this week, as 76 S&P 500 companies are scheduled to report. IBM and J.B. Hunt Transport Services will be Monday’s highlights, followed by Netflix, Chipotle Mexican Grill, Halliburton, Intuitive Surgical, and United Airlines Holdings on Tuesday.\nWednesday will be busy, with SAP, Coca-Cola, Johnson & Johnson, Texas Instruments, and Verizon Communications all releasing results. AT&T, Twitter, Biogen, Snap, American Airlines Group, Intel, and Southwest Airlines go next on Thursday, before American Express, Honeywell International, and Schlumberger close the week on Friday.\nThe economic calendar this week will bring plenty of data on the state of the U.S. housing market. On Monday, the National Association of Home Builders releases its NAHB/ Wells Fargo Housing Market Index for July, followed by the Census Bureau’s new residential construction data for June on Tuesday. Then, on Thursday, the National Association of Realtors reports existing-home sales for June. Economists on average expect a still robust housing market, but one that’s less explosively growing than earlier this year.\n\nMonday 7/19\nIBM, J.B. Hunt Transport Services, PPG Industries, Prologis, Tractor Supply, and Zions Bancorp report quarterly results.\nL Brands holds a conference call to discuss the spinoff of its Victoria’s Secret brand. The new company, to be called Victoria’s Secret, is expected to trade under the ticker VSCO on the New York Stock Exchange in early August. The remaining company will be renamed Bath & Body Works, and also have a new stock symbol, BBWI.\nThe National Association of Home Builders releases its NAHB/Wells Fargo Housing Market Index for July. Consensus estimate is for an 82 reading, slightly higher than the June data. Home builders remain quite bullish on the housing market, but the June figure was the lowest since August 2020, amid rising materials prices and supply-chain shortages.\nTuesday 7/20\nChipotle Mexican Grill, Citizens Financial Group, Halliburton, HCA Healthcare, Intuitive Surgical, KeyCorp, Netflix, Philip Morris International, Synchrony Financial, Travelers, and United Airlines Holdings announce earnings.\nThe Census Bureau reports new residential construction data for June. Economists forecast a seasonally adjusted annual rate of 1.6 million housing starts, slightly more than the June figure.\nWednesday 7/21\nAnthem, ASML Holding, Baker Hughes, Coca-Cola, Crown Castle International, CSX, Johnson & Johnson, Nasdaq, Northern Trust, Novartis, SAP, Seagate Technology Holdings, Texas Instruments, and Verizon Communications release quarterly results.\nThursday 7/22\nThe NAR reports existing-home sales for June. Economists forecast a seasonally adjusted annual rate of 5.8 million, matching the May figure. Existing-home sales have declined for four consecutive months.\nAbbott Laboratories, American Airlines Group, AT&T, Biogen, Capital One Financial, D.R. Horton, Danaher, Intel, Marsh & McLennan, Newmont, Nucor, Snap, Southwest Airlines, Twitter, and Union Pacific hold conference calls to discuss earnings.\nThe Conference Board releases its Leading Economic Index for June. Consensus estimate is for a 1.1% month-over-month increase, after a 1.3% rise in May. The LEI has now surpassed its previous peak from January 2020.\nThe European Central Bank announces its monetary-policy decision. The central bank is widely expected to keep its key short-term interest rate unchanged at negative 0.5%. The ECB recently changed its inflation goal to 2% over the medium term instead of targeting inflation of close to, but below, 2%.\nFriday 7/23\nAmerican Express, Honeywell International, Kimberly-Clark, NextEra Energy, and Schlumberger report quarterly results.","news_type":1},"isVote":1,"tweetType":1,"viewCount":182,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":176048324,"gmtCreate":1626849278368,"gmtModify":1703479244841,"author":{"id":"4089540340634350","authorId":"4089540340634350","name":"Jillwong26","avatar":"https://static.tigerbbs.com/361c1d2946a05e887ab9e2177a2f2486","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089540340634350","authorIdStr":"4089540340634350"},"themes":[],"htmlText":"[OMG] ","listText":"[OMG] ","text":"[OMG]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/176048324","repostId":"2153866611","repostType":4,"repost":{"id":"2153866611","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1626847800,"share":"https://ttm.financial/m/news/2153866611?lang=&edition=fundamental","pubTime":"2021-07-21 14:10","market":"sh","language":"en","title":"Johnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says study","url":"https://stock-news.laohu8.com/highlight/detail?id=2153866611","media":"Dow Jones","summary":"JNJ says data from study 'do not speak to the full nature of immune protection'.\n\nThe one-shot coron","content":"<blockquote>\n JNJ says data from study 'do not speak to the full nature of immune protection'.\n</blockquote>\n<p>The <a href=\"https://laohu8.com/S/AONE.U\">one</a>-shot coronavirus vaccine from Johnson & Johnson is much less effective against the Delta variant than it is against the original version of COVID-19, according to a new study posted online Tuesday.</p>\n<p>The study, which examined blood samples in a laboratory setting and has not yet been peer-reviewed, suggests that anyone who received the J&J <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> vaccine may need to receive a second shot as the variant continues to spread across the US.</p>\n<p>\"The message that we wanted to give was not that people shouldn't get the J&J vaccine, but we hope that in the future, it will be boosted with either another dose of J&J or a boost with Pfizer or Moderna,\" study leader Nathaniel Landau, a virologist at NYU's Grossman School of Medicine, told The New York Times .</p>\n<p>Earlier this month, New Jersey-based Johnson & Johnson published preliminary data indicating its vaccine was effective against the Delta variant, first located in India, at least eight months after inoculation.</p>\n<p>However, in May, the British government released a study vaccine, which is similar in structure to the Johnson & Johnson vaccine, was just 33 percent effective against \"symptomatic disease\" caused by the Delta variant, while two doses were 60 percent effective against symptomatic disease.</p>\n<p>J&J spokesperson Seema Kumar told the Times that the data from the latest study \"do not speak to the full nature of immune protection.\"</p>\n<p>Last month, Centers for Disease Control and Prevention <a href=\"https://laohu8.com/S/CDC\">$(CDC)$</a> Director Dr. Rochelle Walensky told NBC's \"Today\" show that \"we have every reason to believe ... that the J&J will perform well against the Delta variant, as it has so far against other variants circulating in the United States.\"</p>\n<p>Walensky told lawmakers earlier Tuesday that the Delta variant currently accounts for 83 percent of all COVID-19 cases in the US. During the same hearing, White House chief medical adviser Dr. Anthony Fauci said researchers were still assessing whether booster shots would be needed to provide additional protection.</p>\n<p>\"We don't want people to believe that when you're talking about boosters, that means the vaccines aren't effective,\" Fauci said. \"They are highly effective, we are talking about the durability of that.\"</p>\n<p>Initial studies indicate that mRNA vaccines manufactured by Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> and Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> are effective against the Delta variant and could provide protection for years, provided the virus doesn't mutate far beyond its initial form.</p>\n<p>The Delta variant has been blamed for an increase in cases, hospitalizations and deaths in recent weeks, though the numbers in all categories are still well below the peak of last winter's surge and the overwhelming majority of hospitalizations and deaths are occurring among unvaccinated people.</p>\n<p>Despite that, health officials in Los Angeles and Las Vegas have reimposed mask mandates in indoor spaces, regardless of individuals' vaccination status.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Johnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJohnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-07-21 14:10</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n JNJ says data from study 'do not speak to the full nature of immune protection'.\n</blockquote>\n<p>The <a href=\"https://laohu8.com/S/AONE.U\">one</a>-shot coronavirus vaccine from Johnson & Johnson is much less effective against the Delta variant than it is against the original version of COVID-19, according to a new study posted online Tuesday.</p>\n<p>The study, which examined blood samples in a laboratory setting and has not yet been peer-reviewed, suggests that anyone who received the J&J <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> vaccine may need to receive a second shot as the variant continues to spread across the US.</p>\n<p>\"The message that we wanted to give was not that people shouldn't get the J&J vaccine, but we hope that in the future, it will be boosted with either another dose of J&J or a boost with Pfizer or Moderna,\" study leader Nathaniel Landau, a virologist at NYU's Grossman School of Medicine, told The New York Times .</p>\n<p>Earlier this month, New Jersey-based Johnson & Johnson published preliminary data indicating its vaccine was effective against the Delta variant, first located in India, at least eight months after inoculation.</p>\n<p>However, in May, the British government released a study vaccine, which is similar in structure to the Johnson & Johnson vaccine, was just 33 percent effective against \"symptomatic disease\" caused by the Delta variant, while two doses were 60 percent effective against symptomatic disease.</p>\n<p>J&J spokesperson Seema Kumar told the Times that the data from the latest study \"do not speak to the full nature of immune protection.\"</p>\n<p>Last month, Centers for Disease Control and Prevention <a href=\"https://laohu8.com/S/CDC\">$(CDC)$</a> Director Dr. Rochelle Walensky told NBC's \"Today\" show that \"we have every reason to believe ... that the J&J will perform well against the Delta variant, as it has so far against other variants circulating in the United States.\"</p>\n<p>Walensky told lawmakers earlier Tuesday that the Delta variant currently accounts for 83 percent of all COVID-19 cases in the US. During the same hearing, White House chief medical adviser Dr. Anthony Fauci said researchers were still assessing whether booster shots would be needed to provide additional protection.</p>\n<p>\"We don't want people to believe that when you're talking about boosters, that means the vaccines aren't effective,\" Fauci said. \"They are highly effective, we are talking about the durability of that.\"</p>\n<p>Initial studies indicate that mRNA vaccines manufactured by Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> and Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> are effective against the Delta variant and could provide protection for years, provided the virus doesn't mutate far beyond its initial form.</p>\n<p>The Delta variant has been blamed for an increase in cases, hospitalizations and deaths in recent weeks, though the numbers in all categories are still well below the peak of last winter's surge and the overwhelming majority of hospitalizations and deaths are occurring among unvaccinated people.</p>\n<p>Despite that, health officials in Los Angeles and Las Vegas have reimposed mask mandates in indoor spaces, regardless of individuals' vaccination status.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153866611","content_text":"JNJ says data from study 'do not speak to the full nature of immune protection'.\n\nThe one-shot coronavirus vaccine from Johnson & Johnson is much less effective against the Delta variant than it is against the original version of COVID-19, according to a new study posted online Tuesday.\nThe study, which examined blood samples in a laboratory setting and has not yet been peer-reviewed, suggests that anyone who received the J&J $(JNJ)$ vaccine may need to receive a second shot as the variant continues to spread across the US.\n\"The message that we wanted to give was not that people shouldn't get the J&J vaccine, but we hope that in the future, it will be boosted with either another dose of J&J or a boost with Pfizer or Moderna,\" study leader Nathaniel Landau, a virologist at NYU's Grossman School of Medicine, told The New York Times .\nEarlier this month, New Jersey-based Johnson & Johnson published preliminary data indicating its vaccine was effective against the Delta variant, first located in India, at least eight months after inoculation.\nHowever, in May, the British government released a study vaccine, which is similar in structure to the Johnson & Johnson vaccine, was just 33 percent effective against \"symptomatic disease\" caused by the Delta variant, while two doses were 60 percent effective against symptomatic disease.\nJ&J spokesperson Seema Kumar told the Times that the data from the latest study \"do not speak to the full nature of immune protection.\"\nLast month, Centers for Disease Control and Prevention $(CDC)$ Director Dr. Rochelle Walensky told NBC's \"Today\" show that \"we have every reason to believe ... that the J&J will perform well against the Delta variant, as it has so far against other variants circulating in the United States.\"\nWalensky told lawmakers earlier Tuesday that the Delta variant currently accounts for 83 percent of all COVID-19 cases in the US. During the same hearing, White House chief medical adviser Dr. Anthony Fauci said researchers were still assessing whether booster shots would be needed to provide additional protection.\n\"We don't want people to believe that when you're talking about boosters, that means the vaccines aren't effective,\" Fauci said. \"They are highly effective, we are talking about the durability of that.\"\nInitial studies indicate that mRNA vaccines manufactured by Moderna $(MRNA)$ and Pfizer $(PFE)$ BioNTech $(BNTX)$ are effective against the Delta variant and could provide protection for years, provided the virus doesn't mutate far beyond its initial form.\nThe Delta variant has been blamed for an increase in cases, hospitalizations and deaths in recent weeks, though the numbers in all categories are still well below the peak of last winter's surge and the overwhelming majority of hospitalizations and deaths are occurring among unvaccinated people.\nDespite that, health officials in Los Angeles and Las Vegas have reimposed mask mandates in indoor spaces, regardless of individuals' vaccination status.","news_type":1},"isVote":1,"tweetType":1,"viewCount":268,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171196206,"gmtCreate":1626710622005,"gmtModify":1703763876126,"author":{"id":"4089540340634350","authorId":"4089540340634350","name":"Jillwong26","avatar":"https://static.tigerbbs.com/361c1d2946a05e887ab9e2177a2f2486","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089540340634350","authorIdStr":"4089540340634350"},"themes":[],"htmlText":"[Smug] ","listText":"[Smug] ","text":"[Smug]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/171196206","repostId":"2152827296","repostType":4,"repost":{"id":"2152827296","kind":"highlight","pubTimestamp":1626663600,"share":"https://ttm.financial/m/news/2152827296?lang=&edition=fundamental","pubTime":"2021-07-19 11:00","market":"us","language":"en","title":"4 Ways I'm Preparing for the Stock Market Bubble to Burst","url":"https://stock-news.laohu8.com/highlight/detail?id=2152827296","media":"Motley Fool","summary":"This incredible rally has to end with a spectacular crash sometime ... right? Maybe.","content":"<p>Does the <b>S&P 500</b>'s nearly 100% gain from last March's low have you a little worried about a pullback? You're not alone. Even though much of this move was a recovery from the steep sell-off sparked by the onset of the COVID-19 pandemic, much of it has also just been plain old bullishness ... perhaps a little too much. Stocks are still chugging along, but at times, it feels like the only thing keeping the rally going is its momentum. That's not good.</p>\n<p>If you're concerned the market bubble is going to pop soon, feel free to rip a few pages out of my personal playbook. Notice that none of them are particularly complicated moves.</p>\n<h3>1. I'm scaling out of frothier, more speculative names</h3>\n<p>I confess, some of the names I've picked up over the course of the past year or so aren't exactly the sorts of stocks I fully intended to hold for the long haul. They were closer to being bets than investments, which can be fun and rewarding but not exactly safe when the market starts to unravel. As the old adage goes, the higher they fly, the farther they fall. That's especially true when a company can't even come close to justifying its stock price with actual fundamentals. Yes, I'm looking at you, <b>AMC Entertainment</b>.</p>\n<p>Most investors innately know this is the smart-money move to make when the broad market is closer to a major high than a major low. Some investors, however, just need to hear someone else say it. I just did.</p>\n<h3>2. I'm prioritizing cash over equities</h3>\n<p>At first glance, this seems a lot like the aforementioned move -- backing off on my exposure to riskier equities. After all, if I'm selling anything, those proceeds are inherently turned into cash anyway.</p>\n<p>To be clear, however, I'm not merely swapping out my more speculative, vulnerable names for more reliable blue chips. I'm reducing my overall exposure to the market by converting a sizable stake of my holdings to cash.</p>\n<p>It's not always a fully understood (or even believed) facet of investing, but \"safe\" stocks like consumer goods names and utilities companies aren't actually protection from a correction. Shares of consumer packaged goods giant <b>Procter & Gamble</b> fell nearly 24% between last year's February high and March low when the coronavirus began to spread across the world, including within the U.S. Utility name <b>The Southern Company</b> fell 39% during this timeframe. Both recovered -- and then some -- but neither actually offered any true defense from sweeping weakness.</p>\n<p>The point is, during market corrections, there's really no place to hide. You'll just have to let the long-term holdings you're committed to take their lumps on faith they'll bounce back. If you don't have that faith with any particular stock, just replace it with cash until the dust settles.</p>\n<h3>3. I'm adding (a little) gold</h3>\n<p>While most stocks are going to be dragged lower by a market-wide correction, not every sort of holding is a stock. There are also bonds and commodities, which still trade independently of equities. That doesn't preclude them from pulling back if and when the stock market does. But if they do peel back, they're doing so independently of the broad market.</p>\n<p>I'm not bothering with bonds right now. Interest rates are pointlessly low, and with inflation seemingly on the verge of racing out of control, bonds are little more than a coin toss at this time anyway.</p>\n<p>Commodities, however, are a different story. If anything, they've become bigger movers against a rising inflation backdrop and a Federal Reserve that's being increasingly pressured to respond. Should stocks tank, commodities -- already pumped and primed -- may see a swell of demand that drives prices higher. The easiest way to plug into this dynamic is with a simple pick like the <b>SPDR Gold Trust</b>.</p>\n<h3>4. Mostly, I'm doing nothing</h3>\n<p>Finally, and perhaps most importantly, I'm doing nothing about a possible market correction.</p>\n<p>You read that right.</p>\n<p>There are two schools of thought behind the decision to do nothing rather than trying to evade the impact of a correction. The first of these is the simple fact that most of my holdings really are long-haul positions I had (and have) every intention of hanging onto through bear markets. One of the greatest upsides of a legitimate buy-and-hold approach is that you don't even have to worry about temporary headwinds.</p>\n<p>The other idea at work here is the fact that guessing the market's next near-term reversal is just darn difficult to do ... so much so that most people don't do it very well. Indeed, the effort to time the stock market's peaks and valleys often does more harm than good, by virtue of getting you out too soon or too late, or getting you back in too soon or too late. The market's going to do what the market's going to do in its own time, and it's<i> not</i> going to telegraph what's around the corner to anyone. The best way to win that game is by not playing it at all.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Ways I'm Preparing for the Stock Market Bubble to Burst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Ways I'm Preparing for the Stock Market Bubble to Burst\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-19 11:00 GMT+8 <a href=https://www.fool.com/investing/2021/07/18/4-ways-im-preparing-for-stock-market-bubble-burst/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Does the S&P 500's nearly 100% gain from last March's low have you a little worried about a pullback? You're not alone. Even though much of this move was a recovery from the steep sell-off sparked by ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/18/4-ways-im-preparing-for-stock-market-bubble-burst/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2021/07/18/4-ways-im-preparing-for-stock-market-bubble-burst/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152827296","content_text":"Does the S&P 500's nearly 100% gain from last March's low have you a little worried about a pullback? You're not alone. Even though much of this move was a recovery from the steep sell-off sparked by the onset of the COVID-19 pandemic, much of it has also just been plain old bullishness ... perhaps a little too much. Stocks are still chugging along, but at times, it feels like the only thing keeping the rally going is its momentum. That's not good.\nIf you're concerned the market bubble is going to pop soon, feel free to rip a few pages out of my personal playbook. Notice that none of them are particularly complicated moves.\n1. I'm scaling out of frothier, more speculative names\nI confess, some of the names I've picked up over the course of the past year or so aren't exactly the sorts of stocks I fully intended to hold for the long haul. They were closer to being bets than investments, which can be fun and rewarding but not exactly safe when the market starts to unravel. As the old adage goes, the higher they fly, the farther they fall. That's especially true when a company can't even come close to justifying its stock price with actual fundamentals. Yes, I'm looking at you, AMC Entertainment.\nMost investors innately know this is the smart-money move to make when the broad market is closer to a major high than a major low. Some investors, however, just need to hear someone else say it. I just did.\n2. I'm prioritizing cash over equities\nAt first glance, this seems a lot like the aforementioned move -- backing off on my exposure to riskier equities. After all, if I'm selling anything, those proceeds are inherently turned into cash anyway.\nTo be clear, however, I'm not merely swapping out my more speculative, vulnerable names for more reliable blue chips. I'm reducing my overall exposure to the market by converting a sizable stake of my holdings to cash.\nIt's not always a fully understood (or even believed) facet of investing, but \"safe\" stocks like consumer goods names and utilities companies aren't actually protection from a correction. Shares of consumer packaged goods giant Procter & Gamble fell nearly 24% between last year's February high and March low when the coronavirus began to spread across the world, including within the U.S. Utility name The Southern Company fell 39% during this timeframe. Both recovered -- and then some -- but neither actually offered any true defense from sweeping weakness.\nThe point is, during market corrections, there's really no place to hide. You'll just have to let the long-term holdings you're committed to take their lumps on faith they'll bounce back. If you don't have that faith with any particular stock, just replace it with cash until the dust settles.\n3. I'm adding (a little) gold\nWhile most stocks are going to be dragged lower by a market-wide correction, not every sort of holding is a stock. There are also bonds and commodities, which still trade independently of equities. That doesn't preclude them from pulling back if and when the stock market does. But if they do peel back, they're doing so independently of the broad market.\nI'm not bothering with bonds right now. Interest rates are pointlessly low, and with inflation seemingly on the verge of racing out of control, bonds are little more than a coin toss at this time anyway.\nCommodities, however, are a different story. If anything, they've become bigger movers against a rising inflation backdrop and a Federal Reserve that's being increasingly pressured to respond. Should stocks tank, commodities -- already pumped and primed -- may see a swell of demand that drives prices higher. The easiest way to plug into this dynamic is with a simple pick like the SPDR Gold Trust.\n4. Mostly, I'm doing nothing\nFinally, and perhaps most importantly, I'm doing nothing about a possible market correction.\nYou read that right.\nThere are two schools of thought behind the decision to do nothing rather than trying to evade the impact of a correction. The first of these is the simple fact that most of my holdings really are long-haul positions I had (and have) every intention of hanging onto through bear markets. One of the greatest upsides of a legitimate buy-and-hold approach is that you don't even have to worry about temporary headwinds.\nThe other idea at work here is the fact that guessing the market's next near-term reversal is just darn difficult to do ... so much so that most people don't do it very well. Indeed, the effort to time the stock market's peaks and valleys often does more harm than good, by virtue of getting you out too soon or too late, or getting you back in too soon or too late. The market's going to do what the market's going to do in its own time, and it's not going to telegraph what's around the corner to anyone. The best way to win that game is by not playing it at all.","news_type":1},"isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171198788,"gmtCreate":1626710528344,"gmtModify":1703763874294,"author":{"id":"4089540340634350","authorId":"4089540340634350","name":"Jillwong26","avatar":"https://static.tigerbbs.com/361c1d2946a05e887ab9e2177a2f2486","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089540340634350","authorIdStr":"4089540340634350"},"themes":[],"htmlText":"Like and share ","listText":"Like and share ","text":"Like and share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/171198788","repostId":"1111084715","repostType":4,"repost":{"id":"1111084715","kind":"news","pubTimestamp":1626649255,"share":"https://ttm.financial/m/news/1111084715?lang=&edition=fundamental","pubTime":"2021-07-19 07:00","market":"us","language":"en","title":"Netflix, AT&T, Snap, Chipotle, Twitter, and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1111084715","media":"Barrons","summary":"Second-quarter earnings season picks up this week, as 76 S&P 500 companies are scheduled to report. ","content":"<p>Second-quarter earnings season picks up this week, as 76 S&P 500 companies are scheduled to report. <a href=\"https://laohu8.com/S/IBM\">IBM</a> and J.B. Hunt Transport Services will be Monday’s highlights, followed by Netflix, Chipotle Mexican Grill, Halliburton, Intuitive Surgical, and United Airlines Holdings on Tuesday.</p>\n<p>Wednesday will be busy, with SAP, Coca-Cola, Johnson & Johnson, Texas Instruments, and Verizon Communications all releasing results. AT&T, <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>, Biogen, Snap, American Airlines Group, Intel, and Southwest Airlines go next on Thursday, before American <a href=\"https://laohu8.com/S/EXPR\">Express</a>, Honeywell International, and Schlumberger close the week on Friday.</p>\n<p>The economic calendar this week will bring plenty of data on the state of the U.S. housing market. On Monday, the National Association of Home Builders releases its NAHB/ Wells Fargo Housing Market Index for July, followed by the Census Bureau’s new residential construction data for June on Tuesday. Then, on Thursday, the National Association of Realtors reports existing-home sales for June. Economists on average expect a still robust housing market, but one that’s less explosively growing than earlier this year.</p>\n<p><img src=\"https://static.tigerbbs.com/7e83f1e4a91566400a5dd6174a1f8ecc\" tg-width=\"1564\" tg-height=\"662\" referrerpolicy=\"no-referrer\"></p>\n<p>Monday 7/19</p>\n<p>IBM, J.B. Hunt Transport Services, PPG Industries, Prologis, Tractor Supply, and Zions Bancorp report quarterly results.</p>\n<p>L Brands holds a conference call to discuss the spinoff of its Victoria’s Secret brand. The new company, to be called Victoria’s Secret, is expected to trade under the ticker VSCO on the New York Stock Exchange in early August. The remaining company will be renamed Bath & Body Works, and also have a new stock symbol, BBWI.</p>\n<p>The National Association of Home Builders releases its NAHB/Wells Fargo Housing Market Index for July. Consensus estimate is for an 82 reading, slightly higher than the June data. Home builders remain quite bullish on the housing market, but the June figure was the lowest since August 2020, amid rising materials prices and supply-chain shortages.</p>\n<p>Tuesday 7/20</p>\n<p>Chipotle Mexican Grill, <a href=\"https://laohu8.com/S/CFG\">Citizens Financial Group</a>, Halliburton, HCA Healthcare, Intuitive Surgical, <a href=\"https://laohu8.com/S/KEY\">KeyCorp</a>, Netflix, Philip Morris International, <a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a>, Travelers, and United Airlines Holdings announce earnings.</p>\n<p>The Census Bureau reports new residential construction data for June. Economists forecast a seasonally adjusted annual rate of 1.6 million housing starts, slightly more than the June figure.</p>\n<p>Wednesday 7/21</p>\n<p>Anthem, ASML Holding, Baker Hughes, Coca-Cola, Crown Castle International, CSX, Johnson & Johnson, Nasdaq, Northern Trust, Novartis, SAP, Seagate Technology Holdings, Texas Instruments, and Verizon Communications release quarterly results.</p>\n<p>Thursday 7/22</p>\n<p>The NAR reports existing-home sales for June. Economists forecast a seasonally adjusted annual rate of 5.8 million, matching the May figure. Existing-home sales have declined for four consecutive months.</p>\n<p>Abbott Laboratories, American Airlines Group, AT&T, Biogen, Capital One Financial, D.R. Horton, Danaher, Intel, Marsh & McLennan, Newmont, Nucor, Snap, Southwest Airlines, Twitter, and Union Pacific hold conference calls to discuss earnings.</p>\n<p>The Conference Board releases its Leading Economic Index for June. Consensus estimate is for a 1.1% month-over-month increase, after a 1.3% rise in May. The LEI has now surpassed its previous peak from January 2020.</p>\n<p>The European Central Bank announces its monetary-policy decision. The central bank is widely expected to keep its key short-term interest rate unchanged at negative 0.5%. The ECB recently changed its inflation goal to 2% over the medium term instead of targeting inflation of close to, but below, 2%.</p>\n<p>Friday 7/23</p>\n<p>American Express, Honeywell International, Kimberly-Clark, NextEra Energy, and Schlumberger report quarterly results.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Netflix, AT&T, Snap, Chipotle, Twitter, and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNetflix, AT&T, Snap, Chipotle, Twitter, and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-19 07:00 GMT+8 <a href=https://www.barrons.com/articles/netflix-at-t-snap-chipotle-twitter-and-other-stocks-for-investors-to-watch-this-week-51626634814?mod=hp_LEAD_3><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Second-quarter earnings season picks up this week, as 76 S&P 500 companies are scheduled to report. IBM and J.B. Hunt Transport Services will be Monday’s highlights, followed by Netflix, Chipotle ...</p>\n\n<a href=\"https://www.barrons.com/articles/netflix-at-t-snap-chipotle-twitter-and-other-stocks-for-investors-to-watch-this-week-51626634814?mod=hp_LEAD_3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","ISBC":"投资者银行",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.barrons.com/articles/netflix-at-t-snap-chipotle-twitter-and-other-stocks-for-investors-to-watch-this-week-51626634814?mod=hp_LEAD_3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111084715","content_text":"Second-quarter earnings season picks up this week, as 76 S&P 500 companies are scheduled to report. IBM and J.B. Hunt Transport Services will be Monday’s highlights, followed by Netflix, Chipotle Mexican Grill, Halliburton, Intuitive Surgical, and United Airlines Holdings on Tuesday.\nWednesday will be busy, with SAP, Coca-Cola, Johnson & Johnson, Texas Instruments, and Verizon Communications all releasing results. AT&T, Twitter, Biogen, Snap, American Airlines Group, Intel, and Southwest Airlines go next on Thursday, before American Express, Honeywell International, and Schlumberger close the week on Friday.\nThe economic calendar this week will bring plenty of data on the state of the U.S. housing market. On Monday, the National Association of Home Builders releases its NAHB/ Wells Fargo Housing Market Index for July, followed by the Census Bureau’s new residential construction data for June on Tuesday. Then, on Thursday, the National Association of Realtors reports existing-home sales for June. Economists on average expect a still robust housing market, but one that’s less explosively growing than earlier this year.\n\nMonday 7/19\nIBM, J.B. Hunt Transport Services, PPG Industries, Prologis, Tractor Supply, and Zions Bancorp report quarterly results.\nL Brands holds a conference call to discuss the spinoff of its Victoria’s Secret brand. The new company, to be called Victoria’s Secret, is expected to trade under the ticker VSCO on the New York Stock Exchange in early August. The remaining company will be renamed Bath & Body Works, and also have a new stock symbol, BBWI.\nThe National Association of Home Builders releases its NAHB/Wells Fargo Housing Market Index for July. Consensus estimate is for an 82 reading, slightly higher than the June data. Home builders remain quite bullish on the housing market, but the June figure was the lowest since August 2020, amid rising materials prices and supply-chain shortages.\nTuesday 7/20\nChipotle Mexican Grill, Citizens Financial Group, Halliburton, HCA Healthcare, Intuitive Surgical, KeyCorp, Netflix, Philip Morris International, Synchrony Financial, Travelers, and United Airlines Holdings announce earnings.\nThe Census Bureau reports new residential construction data for June. Economists forecast a seasonally adjusted annual rate of 1.6 million housing starts, slightly more than the June figure.\nWednesday 7/21\nAnthem, ASML Holding, Baker Hughes, Coca-Cola, Crown Castle International, CSX, Johnson & Johnson, Nasdaq, Northern Trust, Novartis, SAP, Seagate Technology Holdings, Texas Instruments, and Verizon Communications release quarterly results.\nThursday 7/22\nThe NAR reports existing-home sales for June. Economists forecast a seasonally adjusted annual rate of 5.8 million, matching the May figure. Existing-home sales have declined for four consecutive months.\nAbbott Laboratories, American Airlines Group, AT&T, Biogen, Capital One Financial, D.R. Horton, Danaher, Intel, Marsh & McLennan, Newmont, Nucor, Snap, Southwest Airlines, Twitter, and Union Pacific hold conference calls to discuss earnings.\nThe Conference Board releases its Leading Economic Index for June. Consensus estimate is for a 1.1% month-over-month increase, after a 1.3% rise in May. The LEI has now surpassed its previous peak from January 2020.\nThe European Central Bank announces its monetary-policy decision. The central bank is widely expected to keep its key short-term interest rate unchanged at negative 0.5%. The ECB recently changed its inflation goal to 2% over the medium term instead of targeting inflation of close to, but below, 2%.\nFriday 7/23\nAmerican Express, Honeywell International, Kimberly-Clark, NextEra Energy, and Schlumberger report quarterly results.","news_type":1},"isVote":1,"tweetType":1,"viewCount":182,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
